Hot sale Tirzepatide
2113 Inquiries
2023788-19-2
Pharmaceutical Grade
98%
Beijing
Farmasino
10 ml/bottle
2026-10-09
Acesulfame k,Aspartame,BCAA(Keratin hydrolyzed),Beta-alanine,Citric Acid,Conjugated Linoleic Acid Powder
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.
Basic Info-
Product Name:
Tirzepatide
Other Name:LY3298176;
CAS No.:2023788-19-2
Molecular Formula:C225H348N48O68
Molecular Weight:4813
EC Number:200-001-8
Categories:
Characteristics-
Appearance:
White to off-white
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Acesulfame k,Aspartame,BCAA(Keratin hydrolyzed),Beta-alanine,Citric Acid,Conjugated Linoleic Acid Powder
-
Location:
FARMASINO PHARMACEUTICALS (JIANGSU) CO., LTD.
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A
-
Average lead Time:
10 days
-
Total Annual Revenue:
Above $100 million
-
Year of Establishment:
2008
FarmaSino Pharmaceuticals (Jiangsu) Co., Ltd (As “FarmaSino”) is one of the key subsidiaries of HIGH HOPE International Group , which is one of the largest companies in the "China Top 500”.It is mainly engaged in the R&D, Manufacturing and Distribution of Finished Drugs, Bulk Pharmaceutic
als, and Intermediates&Chemicals. Its commodities are being exported to more than 60 countries and regions in the world, trusted by customers from the globe.FarmaSino is an excellent company involved in many fields, and has improved its management by ISO9001 and endeavored to approach international advanced level all the time . Since it was founded, FarmaSino has constantly devoted to establishing business innovation, industrialization and branding. Based on its business, FarmaSino has built its own manufacture plants for Finished Drugs, Bulk Pharmaceuticals, and Intermediates & Chemicals . Also FarmaSino has established a R&D Centre which possesses advanced equipments and experienced experts.
FarmaSino has constantly emphasized that the core of its business is to establish the strategic alliance partnerships with both up-and-down-stream customers all over the world. Therefore FarmaSino has achieved high reputation in the field of pharmaceuticals, chemicals , agrochemicals and veterinary by offering top quality and personalized services to our customers.
"Clients’ satisfaction is our responsibility”, FarmaSino should be your best partner in Pharmaceutical and Chemicals business.
-
-
Inquiry History2113 Inquiries
Country Product Purchase Quantity Date Posted
United States
2023788-19-2 in unlabeled vials 10, 15 and 30 mg
10 Feb 14, 2024
United States
Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss 399 Inquiries
10 MG Apr 3, 2024
United States
Tirzepatide Raw Powder Weight Loss Peptides CAS No 2023788-19-2 Tirzepatide Injection Peptides
2 MT Dec 13, 2025
Brazil
2023788-19-2
20 PCS Sep 12, 2026
Germany
2023788-19-2
1 MG Jun 18, 2026
United States
2023788-19-2 Trizepatide
10 MT Oct 29, 2023
United States
Tirzepatide 2023788-19-2
2 Feb 19, 2024
United States
Tirzepatide 2023788-19-2
10 G Oct 31, 2023
United States
Trizepatide 2023788-19-2 Raw Material LY3298176 Tirzepatide powder
1 Dec 2, 2025
United States
Fat Burning Peptides Tirzepatide 10mg/Vial 15mg/Vial Tirzepatide CAS: 2023788-19-2
1 MT Jan 25, 2024
United States
Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide
1 MT Oct 20, 2023
United States
Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss
2 KG Oct 20, 2023
United States
supply Tirzepatide Safe Material Shipping Trizepatide 2023788-19-2 Raw Tirzepatide powder
10 MG Apr 4, 2024
Kenya
Janoshik Test Tirzepatide 99% White powder High Quality Tirzepatide Weight loss CAS 2023788-19-2
30 MG Dec 26, 2025
United States
Ex-factory price tirzepatide T30 10vials 30mg kit cas 2023788-19-2 for weight loss peptide
10 Dec 30, 2024
United Kingdom
Manufacturer supply high quality hot sale lowest price Tirzepatide CAS NO,2023788-19-2 99% powder 2023788-19-2 Claire
100 G Nov 4, 2023
Canada
99.9% Purity GLP-1 Injection Weight Loss Peptides Liraglutide Retatrutide Tirzepatide Semaglutide 5mg 10mg CAS 2023788-19-2
2 MT Oct 22, 2023
Poland
TIRZEPATIDE
10 MG Feb 18, 2026
Bolivia
peptideos
10000 G Feb 12, 2026
United Kingdom
tirzepatide
10 MG Oct 21, 2025 Post an enquiry for this product
More from this Seller
-
-
-
Ethanol ETHYL ALCOHOL 99.9% liquid
Pharmaceutical Grade / 99.9%
-
-
-
-
thionyl chloride 99% liquid 99% liquid
Industrial Grade / 99%
-
-
-
-
Isopropyl alcohol 99% liquid
Industrial Grade / 99%
-
-
-
-
FUMARIC ACID 99% liquid
Industrial Grade / 99%
-